By Adjunct Professor Michael Leonard Friedlander

Conference Papers

Bennett BK; Goldstein D; Friedlander ML; Boyle F; De Souza PL; Wilken N; Hickie IB; Scott E; Lloyd AR, 2008, 'A prospective cohort study of fatigue after adjuvant therapy for breast cancer', in Psycho - Oncology, John Wiley & Sons Ltd, Chichester, W Sussex, England, pp. S36 - S37, presented at Psycho-Oncology 2008

Friedlander M; Hancock KC; Benigno B; Rischin D; Messing M; Stringer CA; Tay EH; Kathman S; Matthys G; Lager JJ, 2007, 'Pazopanib (GW786034) is active in women with advanced epithelial ovarian, fallopian tube and peritoneal cancers: Initial results of a phase II study', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY

Peate ML; Meiser B; Hickey MS; Thewes B; Butow PN; Saunders C; Rovelli S; Zorbas H; Friedlander ML, 2007, 'Breast cancer and fertility: Making hard choices easier - The development and evaluation of fertility-related decision aid for young women with early breast cancer', in Psycho - Oncology, John Wiley & Sons Ltd, Chichester, W Sussex, England, pp. S15 - S16, presented at Psycho-Oncology 2007

Dawson S; McKinley J; Jenkins M; McLachlan S; Lindeman G; Friedlander M; Hopper J; Phillips K, 2006, 'Cancer risk management practices of non-carriers within BRCA1/2 mutation positive families in the Kathleen Cunningham Consortium for Research into Familial Breast Cancer (kConFab).', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, GA, Atlanta, pp. 53S - 53S, presented at 42nd Annual Meeting of the American-Society-of-Clinical-Oncology, GA, Atlanta, 02 June 2006 - 06 June 2006, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000239009400210&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Thigpen T; Stuart G; du Bois A; Friedlander M; Fujiwara K; Guastalla JP; Kaye S; Kitchener H; Kristensen G; Mannel R; Meier W; Miller B; Poveda A; Provencher D; Stehman F; Vergote I, 2005, 'Clinical trials in ovarian carcinoma: Requirements for standard approaches and regimens', in Annals of Oncology, pp. viii13 - viii19, http://dx.doi.org/10.1093/annonc/mdi962

Mitchell P; Goldstein D; Michael M; Beale P; Friedlander M; Zalcberg J; Clarke S; White S, 2005, 'Addition of gabapentin (G) to a modified FOLFOX regimen does not reduce neurotoxicity in patients (pts) with advanced colorectal cancer (CRC).', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, FL, Orlando, pp. 266S - 266S, presented at 41st Annual Meeting of the American-Society-of-Clinical-Oncology, FL, Orlando, 13 May 2005 - 17 May 2005, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000230326601475&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Smerud P; Rosenfarb IS; Friedlander ML, 2005, 'Alliances and family psychoeducation: A prospective change-process study', in SCHIZOPHRENIA BULLETIN, OXFORD UNIV PRESS, GA, Savannah, pp. 605 - 606, presented at 10th International Congress on Schizophrenia Research, GA, Savannah, 02 April 2005 - 06 April 2005

Friedlander ML; Bishop J; Levi J; Zalcberg JR; Olver IN; Smith JV; Toner GC, 2005, 'A phase II trial of Paclitaxel in previously treated patients with metastatic breast cancer.', in Medical Journal of Australia, Australasian Med Publishing Company Ltd, Sydney, NSW, Australia, pp. 520 - 523, presented at Medical Journal of Australia

Thewes B; Meiser B; Duric V; Stockler M; Friedlander M, 2004, 'What survival benefits do pre-menopausal early breast cancer patients consider necessary to make endocrine therapy worthwhile?', in PSYCHO-ONCOLOGY, JOHN WILEY & SONS LTD, pp. S40 - S41, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000223957800084&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Aghmesheh M; Friedlander M; Russell PJ; Edwards L; Yang JL; Kconfab K; Nesland JM; Danielson H; Kaern J; Tucker KM, 2004, 'BRCA1 mutation site may associate with nuclear DNA content in BRCA1-associated ovarian carcinomas.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, LA, New Orleans, pp. 459S - 459S, presented at 40th Annual Meeting of the American-Society-of-Clinical-Oncology, LA, New Orleans, 05 June 2004 - 08 June 2004, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000223512401819&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Loi S; Milne RL; Friedlander ML; McCredie MRE; Giles GG; Hopper JL; Phillips KA, 2004, 'The impact of obesity on outcomes in a population-based cohort of women with early-onset breast cancer.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, LA, New Orleans, pp. 845S - 845S, presented at 40th Annual Meeting of the American-Society-of-Clinical-Oncology, LA, New Orleans, 05 June 2004 - 08 June 2004, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000223512403351&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Thewes B; Meiser B; Rickard J; Friedlander M, 2003, 'The fertility and menopause related information needs of younger women with a diagnosis of breast cancer', in PSYCHO-ONCOLOGY, JOHN WILEY & SONS LTD, pp. S125 - S125, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000183225400153&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Aghmesheh M; Edwards L; Clarke CL; Russell PJ; Friedlander ML; Tucker K; Defazio A, 2002, 'Steroid hormone receptor expression in heriditary and sporadic ovarian cancers', in Proceedings of the American Association for Cancer Research, American Association Cancer Research, Philadelphia, PA, USA, pp. 6 - 6, presented at 93rd Annual Meeting of the AACR, San Francisco, California USA, 06 April 2002 - 10 April 2002

Friedlander M, 2001, 'Inorganic nutrition in pond cultivated Gracilaria conferta (Rhodophyta): nitrogen, phosphate and sulfate', in Journal of Applied Phycology, Springer Nature, pp. 279 - 286, http://dx.doi.org/10.1023/a:1011139329415

Summers R; Aguilar E; Friedlander M, 2000, 'Post-natal retinal vascular angiogenesis is dependent on integrins and astrocytes', in MOLECULAR BIOLOGY OF THE CELL, AMER SOC CELL BIOLOGY, pp. 400A - 400A

Katz S; Kizner Z; Dubinsky Z; Friedlander M, 2000, 'Responses of Porphyra linearis (Rhodophyta) to environmental factors under controlled culture conditions', in Journal of Applied Phycology, Springer Nature, pp. 535 - 542, http://dx.doi.org/10.1023/a:1008138227520

Apicella C; Andrews L; Tucker K; Bankier A; Friedlander M; Venter D; Hopper J, 1999, 'Australian Jewish women's experiences with a breast cancer gene testing program as part of the co-operative family registry for breast cancer studies (CFR-BCS).', in AMERICAN JOURNAL OF HUMAN GENETICS, UNIV CHICAGO PRESS, pp. A191 - A191, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000082879801051&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Links M; Friedlander M; Russell P, 1999, 'Enhancement of cisplatin cytotoxicity by caffeine does not correlate with abrogation of G2 arrest.', in BRITISH JOURNAL OF CANCER, CHURCHILL LIVINGSTONE, pp. 42 - 42, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000081955000151&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bishop DT; Rapley E; Tucker K; Collins F; Donald J; Friedlander M; Peng HQ; Goss P; Hogg D; Easton DF; Teare D; Crockford G; Forman D; Leahy M; Bodmer JG; Moses J; Tonks S; Oliver RTD; Biggs P; Seal S; Barfoot R; Gill S; Patel S; Hamoudi R; Hunter R; Thomlinson I; Cooper C; Stratton M; Huddart R; Fosså SD; Heimdal K, 1998, 'Candidate regions for testicular cancer susceptibility genes: The International Testicular Cancer Linkage Consortium', in APMIS, pp. 64 - 72, http://dx.doi.org/10.1111/j.1699-0463.1998.tb01320.x

McKiernan CJ; Friedlander M, 1998, 'Processing of the bovine and human retinal rod Na/Ca-K exchangers in vitro and in vivo', in MOLECULAR BIOLOGY OF THE CELL, AMER SOC CELL BIOLOGY, pp. 220A - 220A

Aguilar E; Gigliotti B; Bersaglieri T; Leonard M; Cheresh D; Friedlander M, 1998, 'Role of matrix metalloproteinase-2 (MMP-2) and PEX, a noncatalytic fragment of MMP-2, in corneal angiogenesis', in MOLECULAR BIOLOGY OF THE CELL, AMER SOC CELL BIOLOGY, pp. 167A - 167A

Friedlander M; DeGramont A; Millward MJ; Bell D; Bugat R; Harnett P; Moreno JA; Campbell L; Ripoche V; Kayitalire L, 1997, 'Activity of Gemcitabine in stage 3 or 4 ovarian cancer: Patients previously treated with cisplatin (CP)-containing regimens', in EUROPEAN JOURNAL OF CANCER, PERGAMON-ELSEVIER SCIENCE LTD, pp. 538 - 538, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997XX83000533&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Rapley E; Tucker K; Collins F; Donald J; Friedlander M; Peng HQ; Goss P; Hogg D; Easton DF; Teare D; Bishop DT; Crockford G; Forman D; Leahy M; Bodmer JG; Moses J; Tonks S; Oliver RTD; Biggs P; Seal S; Barfoot R; Gill S; Patel S; Hamoudi R; Hunter R; Thomlinson I; Cooper C; Stratton M; Huddart R; Fossa SD; Heimdal K, 1997, 'Candidate regions for testicular cancer susceptibility genes', in APMIS, WILEY, DENMARK, COPENHAGEN UNIV HOSP, COPENHAGEN, pp. 64 - 70, presented at 4th Copenhagen Workshop on Carcinoma In Situ and Cancer of the Testis - Molecular and Endocrine Aspects, DENMARK, COPENHAGEN UNIV HOSP, COPENHAGEN, 18 May 1997 - 21 May 1997

Weinberger F; Friedlander M; Hoppe H-G, 1997, 'Gracilaria spp. recognizes fragments of its cell wall and reacts to them', in PHYCOLOGIA, INT PHYCOLOGICAL SOC, pp. 122 - 122

Friedlander M; van der Zee C; Mur L, 1997, 'Nitrogen and phosphate feeding regime of Gracilaria sp.', in PHYCOLOGIA, INT PHYCOLOGICAL SOC, pp. 33 - 33

McKiernan CJ; SahinToth M; Friedlander M, 1997, 'The retinal rod Na+/Ca2+-K+ exchanger contains a non-cleaved signal sequence in vitro', in MOLECULAR BIOLOGY OF THE CELL, AMER SOC CELL BIOLOGY, pp. 1138 - 1138

Zalcberg JR; Bishop JF; Millward MJ; Zimet A; Laird J; Barter C; Seward D; McKeage MJ; Friedlander ML; Toner G; Berille J; Blanc C, 1995, 'Interim results of a phase II trial of docetaxel in combination with cisplatin in patients with metastatic or locally advanced non-small cell lung cancer (NSCLC)', in EUROPEAN JOURNAL OF CANCER, PERGAMON-ELSEVIER SCIENCE LTD, pp. 1084 - 1084, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1995TH91901079&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Gonen Y; Kimmel E; TelOr E; Friedlander M, 1995, 'Intercellular assimilate translocation in Gracilaria cornea (Gracilariaceae, Rhodophyta)', in HYDROBIOLOGIA, KLUWER ACADEMIC PUBL, CHILE, VALDIVIA, pp. 421 - 428, presented at 15th International Seaweed Symposium, CHILE, VALDIVIA

SAHINTOTH M; NICOLL DA; FRANK JS; PHILIPSON KD; FRIEDLANDER M, 1995, 'THE CLEAVED N-TERMINAL SIGNAL SEQUENCE OF THE CARDIAC NA+-CA2+ EXCHANGER IS NOT REQUIRED FOR FUNCTIONAL MEMBRANE INTEGRATION', in MOLECULAR BIOLOGY OF THE CELL, AMER SOC CELL BIOL, pp. 2319 - 2319

FRIEDLANDER M; LEVY I, 1994, 'CULTIVATION OF GRACILARIA IN OUTDOOR TANKS AND PONDS', in JOURNAL OF APPLIED PHYCOLOGY, KLUWER ACADEMIC PUBL, ITALY, TRIESTE, pp. 315 - 324, presented at Workshop on Gracilaria and its Cultivation, ITALY, TRIESTE, http://dx.doi.org/10.1007/BF00004005

GONEN Y; KIMMEL E; FRIEDLANDER M, 1992, 'EFFECT OF RELATIVE WATER MOTION ON PHOTOSYNTHETIC RATE OF RED ALGA GRACILARIA-CONFERTA', in HYDROBIOLOGIA, KLUWER ACADEMIC PUBL, FRANCE, BREST, pp. 493 - 498, presented at 14TH INTERNATIONAL SEAWEED SYMP, FRANCE, BREST, 16 August 1992 - 21 August 1992

SVIRSKI E; BEER S; FRIEDLANDER M, 1992, 'GRACILARIA-CONFERTA AND ITS EPIPHYTES .2. INTERRELATIONSHIP BETWEEN THE RED SEAWEED AND ULVA CF LACTUCA', in HYDROBIOLOGIA, KLUWER ACADEMIC PUBL, FRANCE, BREST, pp. 391 - 396, presented at 14TH INTERNATIONAL SEAWEED SYMP, FRANCE, BREST, 16 August 1992 - 21 August 1992

BROWN S; ILAND H; CROAKER G; REPKA E; SINGH S; FRIEDLANDER M; VINCENT P, 1988, 'GENE AMPLIFICATION IN A PIRITREXIM RESISTANT HUMAN-LEUKEMIC CELL-LINE', in AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, ADIS PRESS AUSTRALASIA P/L, pp. 425 - 425

FRIEDLANDER ML; HEDLEY DW; TAYLOR IW; TATTERSALL MHN, 1984, 'THE BIOLOGICAL SIGNIFICANCE OF CELLULAR DNA CONTENT IN OVARIAN-CANCER', in PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, pp. 34 - 34

FRIEDLANDER ML; MUSGROVE L; RUSSELL P; TOPPLIA M; HEDLEY D; TAYLOR IW; TATTERSALL MHN, 1983, 'FLOW CYTOMETRIC ANALYSIS OF DNA CONTENT IN OVARIAN-CANCER', in CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, BLACKWELL SCIENCE, pp. 489 - 489, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1983RB75800115&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Proceedings (Editor of)

Tiller K; Meiser B; Tucker K; Andrews L; Gaff C; Kirk J; Phillips KA; Duding T; Friedlander ML, (eds.), 2003, '6th World Congress Psycho-Oncology', Banff Alberta Canada, presented at 6th World Congress Psycho-Oncology, Banff Alberta Canada, 23 April 2003 - 27 April 2003

Thewes B; Meiser B; Rickard J; Friedlander ML, (eds.), 2003, '6th World Congress Psycho-Oncology', Banff Alberta Canada, presented at 6th World Congress Psycho-Oncology, Banff Alberta Canada, 23 April 2003 - 27 April 2003

Conference Posters

Lemech CR; Friedlander M, 2009, 'Clear cell cancer of the ovary: from resistance to response', Canberra Australia, presented at MOGA Annual Scientific Meeting, Canberra Australia, 12 August 2009 - 14 August 2009, http://onlinelibrary.wiley.com/doi/10.1111/j.1743-7563.2009.01218.x/pdf

Conference Presentations

Hayes S; Friedlander M; Obermair A; Mileshkin L; Janda M; Gordon L; Barnes E; Beesley V; Eakin E; Sommeijer D; Martyn J; Stockler M; Gebski VAL; Naumann F; Schmitz K; Webb P, 2014, 'EXERCISE DURING CHEMOTHERAPY FOR OVARIAN CANCER (ECHO): STUDY DESIGN FEATURES AND OUTCOMES OF A CANCER AUSTRALIA AND CANCER COUNCIL AUSTRALIA FUNDED RANDOMISED, CONTROLLED TRIAL', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344966500161&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Abstracts

Lheureux S; Abelson S; Bauer S; Fabre M; Bernardini M; Plante M; Provencher D; Brand A; Cohen P; Dawson L; Lackie E; Lee YC; Altman A; Lapointe-Milot K; Friedlander M; Brar H; Kim R; Brenton J; Reynolds A; Tu D; Parulekar W; Pugh T; Oza A, 2026, 'Prevalence of clonal hematopoiesis (CH) in BRCA 1/2 mutation carriers enrolled in a randomized prevention trial of acetylsalicylic acid (ASA) – The STICS and STONES study (CCTG-OV25)', in Gynecologic Oncology, Elsevier, Vol. 208, pp. s335 - s336, http://dx.doi.org/10.1016/j.ygyno.2026.01.582

Zwimpfer TA; Ariyaratne D; Fereday S; Traficante N; Kennedy CJ; Alsop K; Au-Yeung G; Friedlander M; Defazio A; Bowtell DDL; Garsed DW, 2026, 'Real-world comparative outcomes of neoadjuvant chemotherapy with interval cytoreductive surgery versus primary cytoreductive surgery in epithelial ovarian cancer: insights from the australian ovarian cancer study (AOCS)', in INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, ELSEVIER, Vol. 36, http://dx.doi.org/10.1016/j.ijgc.2025.103076

Jacob F; Vogel M; Alborelli I; Lienhard M; Whipman J; Wegmann R; Kumar A; Lima R; Tpc TPC; Toussaint N; Singer F; Ledermann JA; Friedlander M; Pelkmans L; Snijder B; Wicki A; Bodenmiller B; Muenst S; Heinzelmann-Schwarz V, 2026, 'Swiss-GO-08/OV-PRECISION: A randomized controlled swiss trial examining the benefit of multimodal guided therapy in ovarian cancer', in International Journal of Gynecological Cancer, Elsevier, Vol. 36, pp. 104212, http://dx.doi.org/10.1016/j.ijgc.2025.104212

Nahm SH; Kiely BE; O'Connell RL; Lee YC; Davis A; Avall-Lundqvist E; Berek JS; Berton D; Donnellan P; Hilpert F; Joly F; Lanceley A; Ledermann JA; Okamoto A; Oza A; Pignata S; Sehouli J; King MT; Friedlander M; Stockler MR; Roncolato FT, 2025, 'Prognostic significance and accuracy of oncologists’ estimates of survival time in recurrent ovarian cancer', in International Journal of Gynecological Cancer, Vol. 35, http://dx.doi.org/10.1016/j.ijgc.2024.100030

Haggstrom L; Lee YC; Ginesta MPB; Jaeger A; Kaiser S; Woopen H; Rhind M; Frenel J-S; Hussain A; Bischof K; Mongillo M; Brodsky AL; Ledermann JA; Ghezelayagh T; Boere IA; Alonso CM; Rosengarten OS; Tucker KM; Friedlander ML; Inhibitors GCICIERTP, 2025, '1077P How long is long enough? An international GCIG collaboration investigating long term outcomes of exceptional responders with platinum sensitive recurrent ovarian cancer treated with PARP inhibitors', in Annals of Oncology, Elsevier, Vol. 36, pp. s722 - s723, http://dx.doi.org/10.1016/j.annonc.2025.08.1715

Nicum S; Ledermann JA; Friedlander ML; Mileshkin L; Lee YC; King MT; Mercieca-Bebber R; Smith J; Wilkinson K; Counsell N, 2025, '1089P Telling it as it is: Quality of life outcomes associated with maintenance olaparib and cediranib following a response to chemotherapy in relapsed platinum-sensitive ovarian cancer', in Annals of Oncology, Elsevier, Vol. 36, pp. s728 - s729, http://dx.doi.org/10.1016/j.annonc.2025.08.1727

Pitiyarachchi O; Sim H-W; OConnell R; Lanceley A; Lobbedez FJ; Hilpert F; Sehouli J; Pignata S; Berton-Rigaud D; Kaminsky-Forrett M-C; Okamoto A; Yoshida Y; Donnellan P; Oza AM; Lindemann K; Berek JS; Ledermann JA; Friedlander ML, 2025, '1131P Upgrading the performance of ECOG performance status in recurrent ovarian cancer (ECOG+)', in Annals of Oncology, Elsevier, Vol. 36, pp. s752, http://dx.doi.org/10.1016/j.annonc.2025.08.1767

Cohen PA; Obermair A; Gebski V; King MT; Butow P; Campbell R; Bilic S; Brand A; Codde J; Goh JCH; Ives A; Kiberu AD; Lawson W; Mellon A; McNally O; Meniawy T; Mileshkin L; Morton R; Webb P; Friedlander ML, 2025, 'CN88 A phase II randomized trial of nurse led telehealth follow-up including patient reported outcomes using the MOST-S26 (measure of ovarian symptoms and treatment concerns) versus routine clinic based or telehealth follow-up, after completion of chemotherapy in patients with ovarian cancer', in Annals of Oncology, Elsevier, Vol. 36, pp. s1650, http://dx.doi.org/10.1016/j.annonc.2025.08.1166

Hayes S; Obermair A; Spence R; Mileshkin L; Davis A; Brand A; Barnes E; Collins L; Andrews J; Janda M; Vagenas D; Adams D; Lee YC; Beesley V; Webb P; Friedlander M; O'Neille H; Williams M; Stockler M, 2025, 'EXERCISE THERAPY ADDED TO FIRST-LINE CHEMOTHERAPY FOR OVARIAN CANCER: EFFECTS ON PROGRESSION-FREE SURVIVAL AND PHYSICAL WELLBEING IN THE RANDOMISED, PHASE 3 ECHO TRIAL (ANZGOG1304/CTC121)', in INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, ELSEVIER, Vol. 35, http://dx.doi.org/10.1016/j.ijgc.2025.102735

Shivasabesan G; Phung J; Perera S; Knights T; Francis K; Wan KM; Rome RM; Friedlander M; Zalcberg J; Lee YC, 2025, 'Patterns of Bevacizumab Use in Australian Patients With Epithelial Ovarian Cancer: A Real-World Study', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 21

Kumari S; Moujaber T; Gloss B; Madsen I; Gao B; Provan P; Srirangan S; Bouantoun N; Kennedy CJ; Traficante N; Friedlander M; Brand AH; Gourley C; Garsed DW; Bowtell DD; Harnett PR; Balleine RL; DeFazio A, 2025, 'Predictors of Treatment Response in Low-Grade Serous Ovarian Cancer Cell Lines', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 21

Back to profile page